openPR Logo
Press release

Diabetic Neuropathy Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis | Serodus, Novartis, Curacle Co., Ltd, Sonnet BioTherapeutics, Inc., Teijin America, Inc., Shangha

03-25-2025 05:20 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Diabetic Neuropathy Pipeline Insights, DelveInsight

Diabetic Neuropathy Pipeline Insights, DelveInsight

Diabetic Neuropathy Pipeline constitutes 20+ key companies continuously working towards developing 25+ Diabetic Neuropathy treatment therapies, analyzes DelveInsight.

Diabetic Neuropathy Overview:

Diabetic neuropathy is a form of nerve damage that develops in individuals with diabetes, particularly those with prolonged poor blood sugar control. It primarily affects the peripheral nerves, which are responsible for sensation and movement in the limbs. There are several types of diabetic neuropathy, including peripheral neuropathy (impacting the hands and feet), autonomic neuropathy (affecting internal organs), proximal neuropathy (causing issues in the thighs, hips, or buttocks), and focal neuropathy (targeting a specific nerve).

The symptoms of diabetic neuropathy vary based on the type and severity of nerve damage. Peripheral neuropathy commonly causes tingling, numbness, or pain in the extremities, which can worsen over time, leading to loss of sensation and movement difficulties. Autonomic neuropathy may result in digestive problems, urinary issues, sexual dysfunction, and heart-related complications. Proximal neuropathy often presents as pain in the thighs, hips, or buttocks, while focal neuropathy leads to sudden, localized pain or weakness in a specific nerve.

Request for a detailed insights report on Diabetic Neuropathy pipeline insights @ https://www.delveinsight.com/report-store/diabetic-neuropathy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

"Diabetic Neuropathy Pipeline Insight 2025" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Diabetic Neuropathy Therapeutics Market.

Key Takeaways from the Diabetic Neuropathy Pipeline Report

DelveInsight's Diabetic Neuropathy pipeline report depicts a robust space with 20+ active players working to develop 25+ pipeline therapies for Diabetic Neuropathy treatment.
Key Diabetic Neuropathy companies such as Serodus, Novartis, Curacle Co., Ltd, Sonnet BioTherapeutics, Inc., Teijin America, Inc., Shanghai Pharmaceuticals Holding Co., Ltd, ChemoCentryx, Roche, Cyclerion Therapeutics, Inversago Pharma Inc, Sunshine Lake Pharma Co., Ltd., Goldfinch Bio, Cosette Pharmaceuticals, Boehringer Ingelheim, Chinook Therapeutics, and others are evaluating new drugs for Diabetic Neuropathy to improve the treatment landscape.
Promising Diabetic Neuropathy pipeline therapies in various stages of development include SER 150, LMB-763, CU01, and others.

Recent breakthroughs in the Diabetic Neuropathy Pipeline Segment:

In January 2024, Neuralace Medical received FDA clearance for Axon Therapy, a non-invasive magnetic peripheral nerve stimulation (mPNS) treatment for chronic painful diabetic neuropathy (PDN). This therapy delivers painless magnetic pulses during 13.5-minute sessions, offering a novel approach to pain management. A double-blind, multicenter randomized controlled trial demonstrated a 72.3% responder rate and a 57.6% average reduction in pain scores at 30 days. By 90 days, responder rates increased to 81.4% in the treatment group.

Diabetic Neuropathy Pipeline Analysis
The report provides insights into:
The report provides detailed insights into the key companies that are developing therapies in the Diabetic Neuropathy Market.
The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Diabetic Neuropathy treatment.
It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Diabetic Neuropathy market.

Download our free sample page report on Diabetic Neuropathy pipeline insights @ https://www.delveinsight.com/sample-request/diabetic-neuropathy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Diabetic Neuropathy Emerging Drugs

SER 150: Serodus
LMB-763: Novartis
CU01: Curacle Co., Ltd

Diabetic Neuropathy Companies

More than 20 key companies are actively developing therapies for Diabetic Neuropathy. Among them, Serodus has a drug candidate in the most advanced stage of development, specifically in Phase II/III clinical trials.

DelveInsight's report covers around 25+ products under different phases of clinical development like

Late stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I) along with the details of
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates

Diabetic Neuropathy pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

Intravenous
Subcutaneous
Oral
Intramuscular

Diabetic Neuropathy Products have been categorized under various Molecule types such as

Monoclonal antibody
Small molecule
Peptide

Download Sample Pages to Get an in-depth Assessment of the Emerging Diabetic Neuropathy Therapies and Key Companies: Diabetic Neuropathy Clinical Trials and advancements @ https://www.delveinsight.com/report-store/diabetic-neuropathy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Diabetic Neuropathy Pipeline Therapeutic Assessment
• Diabetic Neuropathy Assessment by Product Type
• Diabetic Neuropathy By Stage
• Diabetic Neuropathy Assessment by Route of Administration
• Diabetic Neuropathy Assessment by Molecule Type

Download Diabetic Neuropathy Sample report to know in detail about the Diabetic Neuropathy treatment market @ Diabetic Neuropathy Therapeutic Assessment @ https://www.delveinsight.com/sample-request/diabetic-neuropathy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Table of Content

1. Report Introduction
2. Executive Summary
3. Diabetic Neuropathy Current Treatment Patterns
4. Diabetic Neuropathy - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Diabetic Neuropathy Late-Stage Products (Phase-III)
7. Diabetic Neuropathy Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Diabetic Neuropathy Discontinued Products
13. Diabetic Neuropathy Product Profiles
14. Diabetic Neuropathy Key Companies
15. Diabetic Neuropathy Key Products
16. Dormant and Discontinued Products
17. Diabetic Neuropathy Unmet Needs
18. Diabetic Neuropathy Future Perspectives
19. Diabetic Neuropathy Analyst Review
20. Appendix
21. Report Methodology

Request the Sample PDF to Get Detailed Insights About the Diabetic Neuropathy Pipeline Reports Offerings: https://www.delveinsight.com/report-store/diabetic-neuropathy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Contact Info:
Kritika Rehani
krehani@delveinsight.com
info@delveinsight.com
+14699457679

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Diabetic Neuropathy Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis | Serodus, Novartis, Curacle Co., Ltd, Sonnet BioTherapeutics, Inc., Teijin America, Inc., Shangha here

News-ID: 3936999 • Views:

More Releases from DelveInsight Business Research LLP

Pemphigus Vulgaris Market Size (7MM) is going to be ~USD 360 million in 2025, and expected to grow with a CAGR of 3.6% during the forecast period (2025-2034) | DelveInsight
Pemphigus Vulgaris Market Size (7MM) is going to be ~USD 360 million in 2025, an …
(Albany, USA) DelveInsight's "Pemphigus Vulgaris Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Pemphigus Vulgaris, historical and forecasted epidemiology as well as the Pemphigus Vulgaris market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. Explore In-depth insights into the evolving Pemphigus Vulgaris Market. Download sample report @ https://www.delveinsight.com/sample-request/pemphigus-vulgaris-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Pemphigus Vulgaris Market Report • Among the 7MM, the United
Underactive Bladder Therapeutics Market Size in the 7MM is Expected to Grow Major Growth by 2034, estimates DelveInsight
Underactive Bladder Therapeutics Market Size in the 7MM is Expected to Grow Majo …
DelveInsight's "Underactive Bladder Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Underactive Bladder, historical and forecasted epidemiology as well as the Underactive Bladder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. Explore In-depth insights into the evolving Underactive Bladder Market. Download sample report @ https://www.delveinsight.com/sample-request/underactive-bladder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Underactive Bladder Market Report • In 2023, the prevalent cases of LUTS
The Peripheral Nerve Injury Market Size (7MM) was ~USD 2.4 Billion in 2023, it is projected to grow by 2034, estimates DelveInsight
The Peripheral Nerve Injury Market Size (7MM) was ~USD 2.4 Billion in 2023, it i …
(Albany, USA) DelveInsight's "Peripheral Nerve Injury Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Peripheral Nerve Injury, historical and forecasted epidemiology as well as the Peripheral Nerve Injury market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. Explore In-depth insights into the evolving Peripheral Nerve Injury Market. Download sample report @ https://www.delveinsight.com/sample-request/peripheral-nerve-injuries-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Peripheral Nerve Injury
Acute Lymphocytic Leukemia Market Size (7MM) is going to be ~USD 1,878 Million in 2025, and expected to grow with a CAGR of 4.6% during the forecast period (2025-2034) | DelveInsight
Acute Lymphocytic Leukemia Market Size (7MM) is going to be ~USD 1,878 Million i …
(Albany, USA) DelveInsight's "Acute Lymphocytic Leukemia Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Acute Lymphocytic Leukemia, historical and forecasted epidemiology as well as the Acute Lymphocytic Leukemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Explore In-depth insights into the evolving Acute Lymphocytic Leukemia Market. Download sample report @ https://www.delveinsight.com/sample-request/acute-lymphocytic-leukemia-all-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Acute Lymphocytic

All 5 Releases


More Releases for Diabetic

Rising Diabetic Population Fuels Growth In The Diabetic Footwear Market Emerges …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Diabetic Footwear Market Through 2025? The size of the market for diabetic footwear has seen significant expansion in the past few years. From $8.45 billion in 2024, it is set to increase to $9.2 billion in 2025, exhibiting a compound annual growth
Diabetic Socks Market Dynamics Shaped by Rising Diabetic Population - Persistenc …
The diabetic socks market is gaining significant traction worldwide, driven by the rising prevalence of diabetes and related complications such as diabetic neuropathy and foot ulcers. Designed specifically to cater to the needs of diabetic patients, these socks play a crucial role in foot protection by preventing blistering, reducing moisture accumulation, and providing cushioning to minimize the risk of ulcers. This article delves deeply into the diabetic socks market, exploring
Diabetic Food Market
Future Market Insights (FMI) delivers key insights on the global diabetic food market in its latest report titled “Diabetic Food Market: Global Industry Analysis and Opportunity Assessment, 2014 – 2020”. The global diabetic food market is expected to amplify at a CAGR of 5.9% during the forecast period in terms of value due to various factors, regarding which FMI offers fundamental insights in detail in this report. On the basis of
Diabetic Food Market
Diabetes refers to a metabolic disease which leads to high blood sugar levels. The main cause behind diabetes is the insufficient insulin or no response in the body cells where the insulin is produced. Diabetic foods are dietary products rich in carbohydrates and sugar content. They help in controlling rising blood glucose. Diabetic food is low in calorie sweeteners and diet beverages. These products are consumed by diabetic patients and
Demand for Diabetic Socks Due to Rising Prevalence of Diabetic Neuropathy Expect …
According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025. To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/19282 Global Diabetic Socks Market: Factors Impacting the Market The primary factors driving the growth of the global diabetic socks market are increasing
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be